These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2931553)
1. Successful nicotinamide treatment in an autosomal dominant behavioral and psychiatric disorder. Blom W; van den Berg GB; Huijmans JG; Sanders-Woudstra JA J Inherit Metab Dis; 1985; 8 Suppl 2():107-8. PubMed ID: 2931553 [No Abstract] [Full Text] [Related]
2. A pyridoxine-dependent behavioral disorder unmasked by isoniazid. Brenner A; Wapnir RA Am J Dis Child; 1978 Aug; 132(8):773-6. PubMed ID: 150790 [TBL] [Abstract][Full Text] [Related]
3. Megavitamin therapy with severely disturbed children. Roukema RW; Emery L Am J Psychiatry; 1970 Aug; 127(2):249. PubMed ID: 4248672 [No Abstract] [Full Text] [Related]
4. Treatment of polymorphous light eruption with nicotinamide: a pilot study. Neumann R; Rappold E; Pohl-Markl H Br J Dermatol; 1986 Jul; 115(1):77-80. PubMed ID: 2942169 [TBL] [Abstract][Full Text] [Related]
5. Pellagra with colitis due to a defect in tryptophan metabolism. Clayton PT; Bridges NA; Atherton DJ; Milla PJ; Malone M; Bender DA Eur J Pediatr; 1991 May; 150(7):498-502. PubMed ID: 1833200 [TBL] [Abstract][Full Text] [Related]
6. Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study. Chouinard G; Young SN; Annable L; Sourkes TL Acta Psychiatr Scand; 1979 Apr; 59(4):395-414. PubMed ID: 155389 [TBL] [Abstract][Full Text] [Related]
7. [Biochemical mechanism of action of nicotinic acid, nicotinamide, methionine and D-penicillamine in treatment of psychoses]. Kanig K Arzneimittelforschung; 1970 Jul; 20(7):909-11. PubMed ID: 4248467 [No Abstract] [Full Text] [Related]
8. Studies on tryptophan metabolism in ethylism. Allegri G; Allegri L; Costa C; De Antoni A; Strauch P Acta Vitaminol Enzymol; 1975; 29(1-6):169-73. PubMed ID: 146414 [TBL] [Abstract][Full Text] [Related]
9. Tryptophan-nicotinamide combination in the treatment of newly admitted depressed patients. Chouinard G; Young SN; Annable L; Sourkes TL; Kiriakos RZ Commun Psychopharmacol; 1978; 2(4):311-7. PubMed ID: 153217 [No Abstract] [Full Text] [Related]
10. [Niaprazine in behavior disorders in children. Double-blind comparison with placebo]. Franzoni E; Masoni P; Mambelli M; Marzano P; Donati C Pediatr Med Chir; 1987; 9(2):185-7. PubMed ID: 2958783 [TBL] [Abstract][Full Text] [Related]
12. Effect of nicotinamide administration on the tryptophan-nicotinamide pathway in humans. Fukuwatari T; Shibata K Int J Vitam Nutr Res; 2007 Jul; 77(4):255-62. PubMed ID: 18271280 [TBL] [Abstract][Full Text] [Related]
17. Tryptophan in the treatment of depression. Young SN; Chouinard G; Annable L Adv Exp Med Biol; 1981; 133():727-37. PubMed ID: 6459010 [No Abstract] [Full Text] [Related]
18. Tryptophan metabolism "via" nicotimic acid in patients with scleroderma. De Antoni A; Muggeo M; Costa C; Allegri G; Crepaldi G Acta Vitaminol Enzymol; 1976; 30(4-6):134-9. PubMed ID: 145168 [TBL] [Abstract][Full Text] [Related]
19. Contributions of tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase to the conversion of D-tryptophan to nicotinamide analyzed by using tryptophan 2,3-dioxygenase-knockout mice. Maeta A; Sano M; Fukuwatari T; Funakoshi H; Nakamura T; Shibata K Biosci Biotechnol Biochem; 2014; 78(5):878-81. PubMed ID: 25035993 [TBL] [Abstract][Full Text] [Related]
20. Tryptophan-nicotinic acid metabolism in patients with tumours of the bladder. Changes in the excretory products after treatment with nicotinamide and vitamin B6. QUAGLIARIELLO E; TANCREDI F; FEDELE L; SACCONE C Br J Cancer; 1961 Jun; 15(2):367-72. PubMed ID: 13738623 [No Abstract] [Full Text] [Related] [Next] [New Search]